Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

Journal of Experimental Medicine

Volumn 182, Issue 5, 1995, Pages 1259-1264

  Cabrera, Maira ^a   Shaw, Marie Anne ^a   Sharpies, Claire ^a   Williams, Hazel ^a   Castes, Marianella ^b   Convit, Jacinto ^b   Blackwell, Jenefer M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTO DE BIOMEDICINA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN MALARIA; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DELAYED HYPERSENSITIVITY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INTRON; LEISHMANIA BRAZILIENSIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SKIN LEISHMANIASIS;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMAN; INTRONS; LEISHMANIASIS, MUCOCUTANEOUS; LYMPHOTOXIN; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; POLYMORPHISM (GENETICS); RISK; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; VENEZUELA;

EID: 0028832278     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.5.1259     Document Type: Article

References (24)

1. Castes, M., A. Agnelli, O. Verde, and A.J. Rondon. 1983. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin. Immunol. Immunopathol. 27: 176-186.
2. Castes, M., A. Agnelli, and A.J. Rondon. 1984. Mechanisms associated with immunoregulation in human American cutaneous leishmaniasis. Clin. Exp. Immunol. 57:279-286.
3. Castes, M., M. Cabrera, D. Trujillo, andj. Convit. 1988. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis. J. Clin. Microbiol. 26: 1207-1213.
4. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, and R.L. Modlin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1390-1395.
5. Caceres-Dittmar, G., F.J. Tapia, M.A. Sanchez, M. Yamamura, K. Uyemura, R.L. Modlin, B.R. Bloom, andj. Convit. 1993. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin. Exp. Immunol. 91:500-505.
6. Castes, M., D. Trujillo, M.E. Rojas, C.T. Fernandez, L. Araya, M. Cabrera, J. Blackwell, andj. Convit. 1993. Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis. Biol. Res. 26:233-238.
7. McGuire, W., A.S.V. Hill, C.E.M. Allsop, B.M. Greenwood, and D. Kwiatkowski. 1994. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria. Nature (Lond.). 371:508-511.
8. Trowsdale, J. 1993. Genomic structure and function in the MHC. Trends Genet. 9:117-122.
9. Lara, M.L., Z. Layrisse, J.V. Scorza, E. Garcia, Z. Stoikow, J. Granados, and W. Bias. 1991. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum. Immunol. 30:129-135.
10. Wilson, A.G., F.S. di Giovine, A.I.F. Blakemore, and G.W. Duff. 1993. Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFa) gene detectable by Ncol restriction of PCR product. Hum. Mol. Genet. 1:353.
11. Wilson, A.G., J.A. Symons, T.L. McDowell, F.S. di Giovine, and G.W. Duff. 1994. Effects of a tumour necrosis factor (TNF-alpha) promoter base transition on transcriptional activity. Br.J. Rheumatol. 33:89.
12. Messer, G., U. Spengler, M.C. Jung, G. Honold, K. Blomer, G.R. Pape, G. Riethmiiller, andE.H. Weiss. 1991. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-(3 gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J. Exp. Med. 173:209-219.
13. Abraham, L.J., M.A.H. French, and R.L. Dawkins. 1993. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin. Exp. Immunol. 92:14-18.
14. Pociot, F., L. Briant, C.V. Jongeneel, J. Molvig, H. Worsaae, M. Abbal, M. Thomsen, J. Nerup, and A. Cambon-Thomsen. 1993. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF-(3 by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur. J. Immunol. 23:224-231.
15. Convit, J., M. Ulrich, C.T. Fernandez, F.J. Tapia, G. Caceres-Dittmar, M. Castes, and A.J. Rondon. 1993. The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans. R. Soc. Trap. Med. Hyg. 87:444-448.
16. Castes, M., J. Blackwell, D. Trujillo, S. Formica, M. Cabrera, G. Zorrilla, A. Rodas, P.L. Castellanos, andj. Convit. 1994. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I. Skin-test reactivity, T cell proliferation and interferon-gamma production. Vaccine. 12:1041-1051.
17. Sharpies, C.E., M.-A. Shaw, M. Castes, J. Convit, andJ.M. Blackwell. 1994. Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. Vaccine. 12:1402-1412.
18. Cox, N.J., A.P. Mela, C.M. Zmijewski, and R.S. Speilman. 1989. HLA-DR typing "at the DNA level": RFLPs and subtypes detected with a DR(3 cDNA probe. Am. J. Hum. Genet. 43:954-963.
19. Dyer, P., and A. Warrens. 1994. Design and interpretation of studies of the major histocompatibility complex in disease. In HLA and Disease. R. Lechler, editor. Academic Press, London. pp. 93-121.
20. Ott, J. 1991. Analysis of Human Genetic Linkage. The Johns Hopkins University Press, Baltimore, MD. pp. 245-246.
21. Bendtzen, K., N. Morling, A. Fomsgaard, M. Svenson, B. Jakobsen, N. Odum, and A. Svejgaard. 1988. Association between HLA-DR2 and production of tumour necrosis factor a and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand.J. Immunol. 28:599-606.
22. Jacob, C.O., Z. Fronek, G.D. Lewis, M. Koo, J.A. Hansen, and H.O. McDevitt. 1990. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 87:1233-1237.
23. Fugger, L., N. Morling, L.P. Ryder, P. Platz, J. Georgsen, B.K. Jakobsen, A. Svejgaard, K. Dalhoff, and L. Ranek. 1989. Ncol restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNFa) region in primary biliary cirrhosis and in healthy Danes. Scand. J. Immunol. 30: 185-189.
24. Pociot, F., J. Molvig, L. Wogensen, H. Worsaae, H. Dalboge, L. Baek, andj. Nemp. 1991. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand. J. Immunol. 33:37-49.